ArticleDisease markers2022

BUBs Are New Biomarkers of Promoting Tumorigenesis and Affecting Prognosis in Breast Cancer.

Shunan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.